Table 6

Mean change in RQLQ total score

Study
Sample size
Trial duration
Age
% female
TreatmentsPoint reductions
Lumry, 2003
N=147
3 weeks
37 years
51%
Triamcinolone AQ 220 mcg compared with beclomethasone 336 mcg−1.71 compared with −1.79, NS
Berger, 2003
N=295
3 weeks
31.6 years
62%
Triamcinolone AQ 220 mcg compared with Fluticasone 200 mcg−2.4 compared with −2.5, NS
Gross, 2002
N=352
3 weeks
38.8 years
66.5%
Triamcinolone AQ 220 mcg compared with Fluticasone 200 mcg−2.4 compared with −2.5, NS

RQLQ=Rhinoconjunctivitis Quality of Life Questionnaire

From: Results

Cover of Drug Class Review: Nasal Corticosteroids
Drug Class Review: Nasal Corticosteroids: Final Report Update 1 [Internet].
Selover D, Dana T, Smith C, et al.
Portland (OR): Oregon Health & Science University; 2008 Jun.
Copyright © 2008, Oregon Health & Science University, Portland, Oregon.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.